PharmaGroup ApS: Financial statements 2022
CVR: 43324667
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PharmaGroup ApS (CVR 43324667) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,976,522 and a net result of DKK 1,017,604. Equity in the 2022 report amounted to DKK 1,806,627. The solvency ratio was 69.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,976,522
- Profit/Loss
- DKK 1,017,604
- Equity
- DKK 1,806,627
- Total Assets
- DKK 2,584,045
- Employees
- 1
Official annual report
Keep an eye on PharmaGroup ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 30, 2022, PharmaGroup Holding ApS is registered as an owner of PharmaGroup ApS with an ownership share of 100%.
As of June 1, 2022, Amar Fakhry Alaa Al Dyen-Ahmad is registered as director of PharmaGroup ApS.
PharmaGroup ApS was founded on June 1, 2022.
About PharmaGroup ApS
PharmaGroup ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by PharmaGroup Holding ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 5,561,227 and a net result of DKK 2,366,747 compared with DKK 5,037,144 the year before. Equity in the 2025 report amounted to DKK 2,458,279.